What: Emerging studies suggest cannabis‐based therapies may help manage conditions like menstrual pain and menopausal symptoms, opening new avenues for treatment.
Key line: [Details not provided].
Source: MJBizDaily.
An analysis of emerging investment trends shaping the future of women’s health research.
RFK, Jr. is sworn in as HHS secretary and takes a dig at previous agency messaging while promising “the truth” so mothers can make informed decisions.
A comprehensive Danish study reveals that while the absolute risk is low, hormonal contraceptives slightly increase the risk of ischemic stroke and sometimes heart attack.
A study reveals that from 2001 to 2020, early-onset breast cancer rates among women ages 25–39 varied significantly by region in the United States.
A marijuana business trade publication reports that some producers are eyeing cannabis-based treatments for women’s health issues.
A federal judge temporarily halted Trump’s planned deep NIH funding cuts after attorneys general from 22 states sued to block the move.
New York introduces a shield law to protect doctors who prescribe abortion medications.
An intimate essay describes the overwhelming stress of a high-risk pregnancy designation.
Amid administrative chaos, the NIH acting director assured that key research projects would proceed.
A nonprofit representing thousands of physicians is suing to restore access to public health data.
Cosmo UK explores the phenomenon dubbed ‘post‐birth control syndrome’ despite its unofficial status.
Michigan law now allows pharmacists to prescribe birth control amid a shortage of OB/GYNs.
Exclusive subscriber content: a comprehensive report on upcoming shifts in women’s health and a 2024 stories database.
Washington Post columnist Heather Long explains that higher fertility rates are linked to more equitable sharing of housework between couples.
The New York Times investigates whether testosterone therapy could benefit menopausal women.
The Cut’s Beauty Editor examines Botox resistance—a rare phenomenon where antibodies may reduce the effectiveness of neuromodulators like Botox.
Recent studies are examining how hormonal contraceptives affect long-term women’s health.
A California study found that over 60% of pregnancy-related hemorrhage deaths were preventable due to delays in response and inadequate management.
One blood pressure medication outperformed another, potentially lowering postpartum readmission rates.
A JAMA study finds that in states with abortion bans, a modest increase in fertility is accompanied by a significant rise in infant mortality rates.